Magenta Therapeutics, Inc. Business Finance Contracts & Agreements

20 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Dianthus Therapeutics, Inc. 2019 Employee Stock Purchase Plan
Stock Agreements
Magenta Therapeutics, Inc.
Biotechnology
DE
2024
Amendment No. 1 to Stockholder Rights Agreement by and between Magenta Therapeutics, Inc. and Computershare Trust Company, N.A.
Shareholders Agreements
Magenta Therapeutics, Inc.
Biotechnology
DE
2023
Underwriting Agreement for Sale of 7,500,000 Shares of Common Stock by Magenta Therapeutics, Inc. to Goldman Sachs & Co. LLC and Cowen and Company, LLC
Underwriting Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2020
Magenta Therapeutics, Inc. Underwriting Agreement for 7,500,000 Shares of Common Stock with Goldman Sachs & Co. LLC and Cowen and Company, LLC
Underwriting Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2020
Amendment to Exclusive Research, Development Option and License Agreement between Magenta Therapeutics, Inc. and Heidelberg Pharma Research GmbH (Amanitin Toxin Construct Supply...
Modification Agreements
Magenta Therapeutics, Inc.
Biotechnology
2019
Underwriting Agreement between Magenta Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and Cowen and Company, LLC (2019)
Underwriting Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2019
Common Stock Certificate for Magenta Therapeutics, Inc.
Stock Agreements
Magenta Therapeutics, Inc.
Biotechnology
2018
Magenta Therapeutics, Inc. 2016 Stock Option and Grant Plan
Stock Agreements
Magenta Therapeutics, Inc.
Biotechnology
DE
2018
Underwriting Agreement between Magenta Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and Cowen and Company, LLC
Underwriting Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2018
Dianthus Therapeutics, Inc. Stock Option Agreement under Amended and Restated Stock Option and Incentive Plan
Warrant Agreements
Magenta Therapeutics, Inc.
Biotechnology
DE
2024
Description of Dianthus Therapeutics, Inc. Common and Preferred Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Magenta Therapeutics, Inc.
Biotechnology
2024
Registration Rights Agreement between Dianthus Therapeutics, Inc. and Purchasers (January 22, 2024)
Registration Rights Agreements
Magenta Therapeutics, Inc.
Biotechnology
2024
Securities Purchase Agreement between Dianthus Therapeutics, Inc. and Purchasers (January 22, 2024)
Purchase Agreements
Magenta Therapeutics, Inc.
Biotechnology
CA
2024
Dianthus Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock (2024)
Warrant Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2024
Registration Rights Agreement among Dianthus Therapeutics, Inc., Magenta Therapeutics, Inc., and Purchasers (September 11, 2023)
Registration Rights Agreements
Magenta Therapeutics, Inc.
Biotechnology
2023
Dianthus Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock (Warrant No. W-[001])
Warrant Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2023
Securities Purchase Agreement between Magenta Therapeutics, Inc. and Purchasers (May 12, 2021)
Purchase Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2021
Description of Magenta Therapeutics, Inc. Common Stock and Registration Rights Agreement
Registration Rights Agreements
Magenta Therapeutics, Inc.
Biotechnology
2020
Magenta Therapeutics, Inc. 2019 Employee Stock Purchase Plan
Equity Distribution Agreements
Magenta Therapeutics, Inc.
Biotechnology
DE
2019
Second Amended and Restated Investors' Rights Agreement between Magenta Therapeutics, Inc. and Investors (April 2, 2018)
Investor Rights Agreements
Magenta Therapeutics, Inc.
Biotechnology
DE
2018